This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Therapeutic Drug Monitoring Markets

Table 10.5: Top-Selling Pharmaceutical Products by Bayer Healthcare

Pharmaceuticals 161

Table 10.6: Selected Bayer Products undergoing Registration 161

Table 10.7: Bayer -Top Selling Pharmaceutical Products by Sales, 2010-2011 162

Table 10.8: Life Science Product Portfolio – BioRad 163

Table 10.9: Customer Profile of BioRad 163

Table 10.10: Panel of BioRads Life Science Industry Competitors 163

Table 10.11: Panel of BioRads Clinical Diagnostic Industry Competitors 164

Table App 1.1: Variables that Contribute to Therapeutic Drug Monitoring Analysis


Table App 1.2: Common Drug Administration Routes 168

Table App 1.3: CYP Enzyme Metabolism of Clinically Relevant Therapeutic Agents


Table App 1.4: Major Sources of Pharmacokinetic Variability 170

Table App 1.5: Common Drug Groups involved in Therapeutic Drug Monitoring 172

Table App 1.6: Interpretative Criteria for a number of common drugs during

Therapeutic Drug Monitoring 173


Figure 2.1: Pharmacokinetics and TDM Relationship 18

Figure 2.2: Process for Reaching Dosage Decisions with Therapeutic Drug

Monitoring 19

Figure 2.3: Individualized Drug Treatment using Therapeutic Drug Monitoring 19

Figure 2.4: Pharmacokinetics and Pharmacodynamics Contribute to Variability in

the Relationship Between Therapeutic Dose and Effect 20

Figure 2.5: Concept of Therapeutic Range 20

Figure 2.6: Antiretroviral Coverage in Low and Middle Income Countries 24

Figure 2.7: Scenarios for Incremental Expansion of Antiretroviral Provision to

Treat and Prevent HIV 25

Figure 3.1: Number of Depression Sufferers in the U.S. 2005-2010 36

Figure 3.2: The Requirement for Immunosuppressant Drug Monitoring 42

Figure 3.3 Global Summary of the AIDS Epidemic 44

Figure 3.4: Number of People receiving Antiretroviral Therapy 44

Figure 4.1: Global Revenue of Therapeutic Drug Testing Market Forecast,

2009-2017 49

Figure 4.2 Geographic Market Share of the Therapeutic Drug Test Market 50

Figure 4.3: Global Market Share Analysis for Therapeutic Drug Testing (2012) 53

Figure 4.4: U.S. Market Share Analysis – Therapeutic Drug Testing (2012) 54

8 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs